CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Open-market buy Chief Executive Officer bought 16,733 shares at $1.32 ($22,088)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 41,322 shares (grant or award)
- 8-K Event Regulation FD disclosure
Page 29 of 76 · 1,519 filings